<?xml version="1.0" encoding="UTF-8"?>
<p>The average age of the cohort was 65 (63–68) years, with 152 males (60.8%). As shown in 
 <xref rid="T2" ref-type="table">Table 2</xref>, there was no difference between the two groups in baseline features of patients, such as age, sex, medical history, Child–Pugh hepatic function, ASA physical status, operative type, hepatectomy type, and hepatic pathology (
 <italic>P</italic> &gt; 0.05 for all). There was no occurrence of death in the two groups. Clinical outcomes of patients were compared between the two groups in 
 <xref rid="T3" ref-type="table">Table 3</xref>. Patients in the ERAS group had significantly less occurrence of post-operative complications and a shorter length of hospital stay (
 <italic>P</italic> &lt; 0.05 for all). Deep vein thrombosis (DVT) occurred in seven patients in the control group but did not occur in the ERAS group (
 <italic>P</italic> &lt; 0.05). No complication in Grade IIIb, IV, or V occurred in the two groups. Patients in the two groups had similar occurrences of readmission (
 <italic>P</italic> &gt; 0.05).
</p>
